Clinical Trial Update: High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing high-dose versus standard-dose rifampicin for effusive tuberculous pericarditis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Pericarditis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculous Pericarditis, HIV Status | Phase 2 | Status: RECRUITING